Egyban 6mg

Share :

Related Products

Egyban 6mg (Ibandronic Acid) 6mg Injection is a prescription medication used to treat osteoporosis, a condition characterized by brittle and porous bones that can lead to fractures. Composition: Each vial of Egyban contains 6mg of ibandronic acid, a bisphosphonate that inhibits the activity of osteoclasts, the cells responsible for breaking down bone tissue. Mechanism of Action: Ibandronic acid works by:
  • Inhibiting the activity of osteoclasts, which reduces bone resorption and increases bone density
  • Suppressing the formation of new bone by inhibiting the activity of osteoblasts, the cells responsible for forming new bone tissue
  • Reducing the levels of calcium in the blood by inhibiting the absorption of calcium in the gut
Indications: Egyban is indicated for the treatment of:
  • Osteoporosis in postmenopausal women who are at high risk of fracture
  • Osteoporosis in men who are at high risk of fracture
  • Hypercalcemia (elevated levels of calcium in the blood) due to malignancy or other conditions
Administration: Egyban is administered intravenously over a period of approximately 15-30 minutes. The recommended dose is 6mg every 3 months. Side Effects: Common side effects of Egyban include:
  • Nausea
  • Vomiting
  • Abdominal pain
  • Diarrhea
  • Headache
  • Dizziness
Rare but serious side effects include:
  • Osteonecrosis (death of bone tissue) of the jaw or femur
  • Atypical subtrochanteric or diaphyseal femoral fractures (breaks in the thigh bone)
  • Hypocalcemia (low levels of calcium in the blood)
Contraindications: Egyban is contraindicated in patients with:
  • Hypocalcemia (low levels of calcium in the blood)
  • Hypercalcemia (elevated levels of calcium in the blood)
  • History of severe allergic reactions to ibandronic acid or other components of the product
  • Pregnancy or breastfeeding
Precautions: Patients with a history of dental problems or other oral health issues should be monitored closely while using Egyban. Patients with a history of kidney disease or severe kidney impairment should be monitored closely for changes in their kidney function. Interactions: Egyban may interact with other medications, including:
  • Bisphosphonates
  • Corticosteroids
  • Hormone replacement therapy (HRT)
  • Thyroid hormone replacement therapy
Important Note: Egyban should be administered by a healthcare professional in a clinical setting. Patients should be monitored regularly for changes in their bone density, as well as for signs of allergic reactions or other a

Egyban 6mg (Ibandronic Acid) 6mg Injection is a prescription medication used to treat osteoporosis, a condition characterized by brittle and porous bones that can lead to fractures.

Composition:

Each vial of Egyban contains 6mg of ibandronic acid, a bisphosphonate that inhibits the activity of osteoclasts, the cells responsible for breaking down bone tissue.

Mechanism of Action:

Ibandronic acid works by:

  • Inhibiting the activity of osteoclasts, which reduces bone resorption and increases bone density
  • Suppressing the formation of new bone by inhibiting the activity of osteoblasts, the cells responsible for forming new bone tissue
  • Reducing the levels of calcium in the blood by inhibiting the absorption of calcium in the gut

Indications:

Egyban is indicated for the treatment of:

  • Osteoporosis in postmenopausal women who are at high risk of fracture
  • Osteoporosis in men who are at high risk of fracture
  • Hypercalcemia (elevated levels of calcium in the blood) due to malignancy or other conditions

Administration:

Egyban is administered intravenously over a period of approximately 15-30 minutes. The recommended dose is 6mg every 3 months.

Side Effects:

Common side effects of Egyban include:

  • Nausea
  • Vomiting
  • Abdominal pain
  • Diarrhea
  • Headache
  • Dizziness

Rare but serious side effects include:

  • Osteonecrosis (death of bone tissue) of the jaw or femur
  • Atypical subtrochanteric or diaphyseal femoral fractures (breaks in the thigh bone)
  • Hypocalcemia (low levels of calcium in the blood)

Contraindications:

Egyban is contraindicated in patients with:

  • Hypocalcemia (low levels of calcium in the blood)
  • Hypercalcemia (elevated levels of calcium in the blood)
  • History of severe allergic reactions to ibandronic acid or other components of the product
  • Pregnancy or breastfeeding

Precautions:

Patients with a history of dental problems or other oral health issues should be monitored closely while using Egyban. Patients with a history of kidney disease or severe kidney impairment should be monitored closely for changes in their kidney function.

Interactions:

Egyban may interact with other medications, including:

  • Bisphosphonates
  • Corticosteroids
  • Hormone replacement therapy (HRT)
  • Thyroid hormone replacement therapy

Important Note:

Egyban should be administered by a healthcare professional in a clinical setting. Patients should be monitored regularly for changes in their bone density, as well as for signs of allergic reactions or other a

We offer a variety of shipping options, including Express Mail Service (EMS), USPS, DHL, FedEx, TNT, UPS, Aramex, Air Cargo, and sea freight.

Terms and Conditions – 

Bulk Orders: You are responsible for any local import duties and taxes in your country.

For Patients: When ordering prescription medicines for personal use, or for a friend or relative, a valid medical practitioner’s script or prescription is required.

Return and Refund Policy: Due to the nature of our products, we cannot accept returns or exchanges once a purchase is made. However, in the event of non-delivery, you are eligible for either a 100% refund or a reshipment of your order.

Egyban 6mg (Ibandronic Acid) 6mg Injection is a prescription medication used to treat osteoporosis, a condition characterized by brittle and porous bones that can lead to fractures.

Composition:

Each vial of Egyban contains 6mg of ibandronic acid, a bisphosphonate that inhibits the activity of osteoclasts, the cells responsible for breaking down bone tissue.

Mechanism of Action:

Ibandronic acid works by:

  • Inhibiting the activity of osteoclasts, which reduces bone resorption and increases bone density
  • Suppressing the formation of new bone by inhibiting the activity of osteoblasts, the cells responsible for forming new bone tissue
  • Reducing the levels of calcium in the blood by inhibiting the absorption of calcium in the gut

Indications:

Egyban is indicated for the treatment of:

  • Osteoporosis in postmenopausal women who are at high risk of fracture
  • Osteoporosis in men who are at high risk of fracture
  • Hypercalcemia (elevated levels of calcium in the blood) due to malignancy or other conditions

Administration:

Egyban is administered intravenously over a period of approximately 15-30 minutes. The recommended dose is 6mg every 3 months.

Side Effects:

Common side effects of Egyban include:

  • Nausea
  • Vomiting
  • Abdominal pain
  • Diarrhea
  • Headache
  • Dizziness

Rare but serious side effects include:

  • Osteonecrosis (death of bone tissue) of the jaw or femur
  • Atypical subtrochanteric or diaphyseal femoral fractures (breaks in the thigh bone)
  • Hypocalcemia (low levels of calcium in the blood)

Contraindications:

Egyban is contraindicated in patients with:

  • Hypocalcemia (low levels of calcium in the blood)
  • Hypercalcemia (elevated levels of calcium in the blood)
  • History of severe allergic reactions to ibandronic acid or other components of the product
  • Pregnancy or breastfeeding

Precautions:

Patients with a history of dental problems or other oral health issues should be monitored closely while using Egyban. Patients with a history of kidney disease or severe kidney impairment should be monitored closely for changes in their kidney function.

Interactions:

Egyban may interact with other medications, including:

  • Bisphosphonates
  • Corticosteroids
  • Hormone replacement therapy (HRT)
  • Thyroid hormone replacement therapy

Important Note:

Egyban should be administered by a healthcare professional in a clinical setting. Patients should be monitored regularly for changes in their bone density, as well as for signs of allergic reactions or other a

Reviews

There are no reviews yet.

Be the first to review “Egyban 6mg”

Your email address will not be published. Required fields are marked *

Egyban 6mg (Ibandronic Acid) 6mg Injection is a prescription medication used to treat osteoporosis, a condition characterized by brittle and porous bones that can lead to fractures.

Composition:

Each vial of Egyban contains 6mg of ibandronic acid, a bisphosphonate that inhibits the activity of osteoclasts, the cells responsible for breaking down bone tissue.

Mechanism of Action:

Ibandronic acid works by:

  • Inhibiting the activity of osteoclasts, which reduces bone resorption and increases bone density
  • Suppressing the formation of new bone by inhibiting the activity of osteoblasts, the cells responsible for forming new bone tissue
  • Reducing the levels of calcium in the blood by inhibiting the absorption of calcium in the gut

Indications:

Egyban is indicated for the treatment of:

  • Osteoporosis in postmenopausal women who are at high risk of fracture
  • Osteoporosis in men who are at high risk of fracture
  • Hypercalcemia (elevated levels of calcium in the blood) due to malignancy or other conditions

Administration:

Egyban is administered intravenously over a period of approximately 15-30 minutes. The recommended dose is 6mg every 3 months.

Side Effects:

Common side effects of Egyban include:

  • Nausea
  • Vomiting
  • Abdominal pain
  • Diarrhea
  • Headache
  • Dizziness

Rare but serious side effects include:

  • Osteonecrosis (death of bone tissue) of the jaw or femur
  • Atypical subtrochanteric or diaphyseal femoral fractures (breaks in the thigh bone)
  • Hypocalcemia (low levels of calcium in the blood)

Contraindications:

Egyban is contraindicated in patients with:

  • Hypocalcemia (low levels of calcium in the blood)
  • Hypercalcemia (elevated levels of calcium in the blood)
  • History of severe allergic reactions to ibandronic acid or other components of the product
  • Pregnancy or breastfeeding

Precautions:

Patients with a history of dental problems or other oral health issues should be monitored closely while using Egyban. Patients with a history of kidney disease or severe kidney impairment should be monitored closely for changes in their kidney function.

Interactions:

Egyban may interact with other medications, including:

  • Bisphosphonates
  • Corticosteroids
  • Hormone replacement therapy (HRT)
  • Thyroid hormone replacement therapy

Important Note:

Egyban should be administered by a healthcare professional in a clinical setting. Patients should be monitored regularly for changes in their bone density, as well as for signs of allergic reactions or other a

Reviews

There are no reviews yet.

Be the first to review “Egyban 6mg”

Your email address will not be published. Required fields are marked *

Medical Disclaimer

Anteka Pharmacy primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Anteka Pharmacy. Our mission is to support, not replace, the doctor-patient relationship.
Scroll to Top

Log in

Create an Account

Send Enquiry For Egyban 6mg